Microsatellite-stable Colorectal Cancer

• CLINICAL_TRIALS trial_result · 2026-07-22
  Clinical Trial Results: Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer [Phase 2]

  Phase 2 trial of Evorpacept (ALX148) combined with cetuximab and pembrolizumab in refractory microsatellite stable metastatic colorectal can…

• CLINICAL_TRIALS trial_result · 2025-01-28
  Clinical Trial Update: Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer [Phase 2]

  Phase 2 clinical trial of sequential immunochemotherapy in refractory metastatic colorectal cancer, starting with pembrolizumab plus a dendr…

• CLINICAL_TRIALS trial_result · 2023-08-01
  Clinical Trial Update: Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma [Phase 2]

  Phase 2 trial investigating sintilimab and chidamide with or without IBI305 in advanced or metastatic pMMR/MSS colorectal cancer; current st…

• CLINICAL_TRIALS trial_result · 2023-03-14
  Clinical Trial Update: Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC [Phase 3]

  A Phase 3 trial comparing chidamide+syntilimab+bevacizumab versus standard second-line FOLFIRI+bevacizumab in metastatic microsatellite-stab…

• CLINICAL_TRIALS trial_result · 2022-09-08
  Clinical Trial Update: Nivolumab+Ipilimumab+RT in MSS mCRC [Phase 2]

  Phase 2 trial update examining nivolumab + ipilimumab + radiotherapy in metastatic microsatellite stable colorectal cancer.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-06-29
  Clinical Trial Update: Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) [Phase 2]

  Phase 2 trial evaluating the efficacy and safety of Navarixin in combination with pembrolizumab in adults with selected advanced/metastatic …